Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer

Sehui Kim, Ji-Young Jang, Jaemoon Koh, +10

Journal of Experimental & Clinical Cancer Research

Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines

Ji‐Eun Park, Seong‐Eun Kim, Bhumsuk Keam, +7

Journal for ImmunoTherapy of Cancer

Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation

Miso Kim, Suji Kim, Jae Hyang Lim, +3

Journal of Biological Chemistry

Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib

Seulki Kim, Tae Min Kim, Dong‐Wan Kim, +5

Cancer Research and Treatment

Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial

Han‐Byoel Lee, Wonshik Han, Soo‐Yeon Kim, +20

Breast Cancer Research and Treatment

EngineeringNeoadjuvant ChemotherapyMedical ImagingMedicineImage-guided Biopsy +10

Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations

Yusoo Lee, Tae Min Kim, Dong‐Wan Kim, +5

Journal of Thoracic Oncology

Insertion MutationsBone Morphogenic ProteinMolecular BiologyEgfr Exon 20Preclinical Modeling +2

Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma

Ryul Kim, Bhumsuk Keam, Dohee Kwon, +10

World Journal of Gastroenterology

Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer

Su‐Jung Kim, Soyeon Kim, Dong‐Wan Kim, +7

Cancer Research and Treatment

Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor–Positive Early Breast Cancer

Shin Hye Yoo, Tae‐Yong Kim, Miso Kim, +9

Clinical Breast Cancer

21-Gene Prediction AssayBreast OncologyOncologyRecurrence ScoreEngineering +10

Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFRT790M-Mutant NSCLC

Ha-Ram Park, Tae Min Kim, Yusoo Lee, +8

Journal of Thoracic Oncology

MedicineReceptor Tyrosine KinasePharmacologyPathologyPharmacotherapy +3